Sahil Bahri
Senior Associate

Over the course of his academic and professional career, Sahil has cultivated a deep passion for and genuine interest in the intersection of biotechnology and business. 

Prior to joining K2 HealthVentures, Sahil held various investing positions. Most recently he was an Associate on the Investments team at Roivant Sciences serving in the Search and Evaluation and M&A function. Previously, he was an Associate at Woodline Partners, a long / short, market neutral hedge fund where he covered small-mid cap public biotechnology companies. Sahil began his career as a Life Sciences Investment Banking Analyst at Evercore, where he was involved with M&A, joint venture, in-licensing / out-licensing, and capital markets transactions.

Sahil holds dual degrees with a B.A.S. in Bioengineering and a B.S.E in Finance from the University of Pennsylvania School of Engineering and Applied Sciences and the Wharton School, respectively.